Pediatrix Medical Group ( (MD) ) has issued an update.
Pediatrix Medical Group announced a leadership transition with Mark S. Ordan returning as CEO to accelerate the company’s transformational strategy aimed at enhancing shareholder value. The company is refocusing on hospital relationships and patient-centric activities, and expects to achieve the high end of its adjusted EBITDA range for 2024, signaling strong financial performance.
More about Pediatrix Medical Group
Pediatrix Medical Group, Inc. is a leading provider of physician services, focusing on coordinated, compassionate, and clinically excellent services for women, babies, and children in both hospital settings and office-based practices. The company specializes in obstetrics, maternal-fetal medicine, and neonatology, supported by investments in research, education, and safety initiatives. Founded in 1979 as a neonatology practice, it now operates with approximately 4,500 affiliated physicians and clinicians.
YTD Price Performance: -4.53%
Average Trading Volume: 741,933
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $1.07B
See more data about MD stock on TipRanks’ Stock Analysis page.